Ascendis Pharma is a biopharmaceutical company founded in 2007 in Copenhagen, Denmark, focused on developing innovative therapies using its TransCon™ technology. With a commitment to addressing unmet medical needs, Ascendis has a clinical pipeline centered on endocrinology rare diseases and is expanding into oncology and other therapeutic areas. The company operates globally with offices in Germany, the US, and California.